| Year |
Citation |
Score |
| 2020 |
Beaudelot C, Bayart E, Thariat J, Bourgier C, Denis F, Hatt M, Pasquier D, Verry C, Deutsch É, Levy A. [Radiation-oncology horizon 2030: From microbiota to plasma laser]. Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique. PMID 32861611 DOI: 10.1016/J.Canrad.2020.06.023 |
0.31 |
|
| 2020 |
Levy A, Wagner AD, Chargari C, Moehler M, Verheij M, Durand-Labrunie J, Kissel M, Chirat E, Burtin P, Ducreux M, Boige V, Nilsson M, Boku N, Chau I, Deutsch E. Palliation of dysphagia in metastatic oesogastric cancers: An international multidisciplinary position. European Journal of Cancer (Oxford, England : 1990). 135: 103-112. PMID 32563014 DOI: 10.1016/J.Ejca.2020.04.032 |
0.357 |
|
| 2020 |
Escande A, Khettab M, Bockel S, Dumas I, Schernberg A, Gouy S, Morice P, Pautier P, Deutsch E, Haie-Meder C, Chargari C. Interaction between the Number of Chemotherapy Cycles and Brachytherapy Dose/Volume Parameters in Locally Advanced Cervical Cancer Patients. Journal of Clinical Medicine. 9: 1653. PMID 32492777 DOI: 10.3390/Jcm9061653 |
0.335 |
|
| 2020 |
Chargari C, Levy A, Paoletti X, Soria JC, Massard C, Weichselbaum RR, Deutsch E. Methodological Development of Combination Drug and Radiation Therapy in Basic and Clinical Research. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32409306 DOI: 10.1158/1078-0432.Ccr-19-4155 |
0.353 |
|
| 2020 |
Holub K, Busato F, Gouy S, Sun R, Pautier P, Genestie C, Morice P, Leary A, Deutsch E, Haie-Meder C, Biete A, Chargari C. Analysis of Systemic Inflammatory Factors and Survival Outcomes in Endometrial Cancer Patients Staged I-III FIGO and Treated with Postoperative External Radiotherapy. Journal of Clinical Medicine. 9. PMID 32408668 DOI: 10.3390/Jcm9051441 |
0.331 |
|
| 2020 |
Thomas G, Eisenhauer E, Bristow RG, Grau C, Hurkmans C, Ost P, Guckenberger M, Deutsch E, Lacombe D, Weber DC. The European Organisation for Research and Treatment of Cancer, State of Science in radiation oncology and priorities for clinical trials meeting report. European Journal of Cancer (Oxford, England : 1990). 131: 76-88. PMID 32305726 DOI: 10.1016/J.Ejca.2020.02.050 |
0.357 |
|
| 2020 |
Mignot F, Gouy S, Schernberg A, Bockel S, Espenel S, Maulard A, Leary A, Genestie C, Annede P, Kissel M, Fumagalli I, Pautier P, Deutsch E, Haie-Meder C, Morice P, et al. Comprehensive analysis of patient outcome after local recurrence of locally advanced cervical cancer treated with concomitant chemoradiation and image-guided adaptive brachytherapy. Gynecologic Oncology. 157: 644-648. PMID 32173045 DOI: 10.1016/J.Ygyno.2020.03.006 |
0.338 |
|
| 2020 |
Mondini M, Levy A, Meziani L, Milliat F, Deutsch E. Radiotherapy-immunotherapy combinations: perspectives and challenges. Molecular Oncology. PMID 32112478 DOI: 10.1002/1878-0261.12658 |
0.347 |
|
| 2020 |
Levy A, Doyen J, Botticella A, Bourdais R, Achkar S, Giraud P, Du C, Naltet C, Lavaud P, Besse B, Pradère P, Mercier O, Caramella C, Planchard D, Deutsch E, et al. [Role of immunotherapy in locally advanced non-small cell lung cancer]. Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique. PMID 32037126 DOI: 10.1016/J.Canrad.2019.09.007 |
0.351 |
|
| 2020 |
Soysouvanh F, Benadjaoud MA, Santos MD, Mondini M, Lavigne J, Bertho A, Buard V, Tarlet G, Adnot S, Deutsch E, Guipaud O, Paget V, François A, Milliat F. Stereotactic lung irradiation in mice promotes long-term senescence and lung injury. International Journal of Radiation Oncology, Biology, Physics. PMID 31987976 DOI: 10.1016/J.Ijrobp.2019.12.039 |
0.305 |
|
| 2020 |
Seban R, Mezquita L, Berenbaum A, Dercle L, Botticella A, Pechoux CL, Caramella C, Deutsch E, Grimaldi S, Adam J, Ammari S, Planchard D, Leboulleux S, Besse B. Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors. European Journal of Nuclear Medicine and Molecular Imaging. 47: 1147-1157. PMID 31754795 DOI: 10.1007/S00259-019-04615-X |
0.309 |
|
| 2020 |
Joseph A, Castedo-Delrieu M, Bloy N, Labaied N, Mondini M, Loi M, Klein C, Genestie C, Pautier P, Morice P, Gouy S, Deutsch E, Chargary C, Kroemer G, Michels J. Prognostic value of dendritic cells in locally advanced cervical cancer patients. Journal of Clinical Oncology. 38: e18016-e18016. DOI: 10.1200/Jco.2020.38.15_Suppl.E18016 |
0.326 |
|
| 2020 |
Yang E, Deutsch E, Mehmet A, Fayette J, Nabell L, Spencer S, Dobelbower M, Willey C, Bonner J, Wang X, Lin A, William W. A phase 1b trial of prexasertib in combination with chemoradiation in patients with locally advanced head and neck squamous cell carcinoma (HNSCC) International Journal of Radiation Oncology*Biology*Physics. 106: 1136. DOI: 10.1016/J.Ijrobp.2019.11.193 |
0.312 |
|
| 2019 |
De Baere T, Pracht M, Rolland Y, Nguyen F, Bronowicki J, Vendrely V, Cunha AS, Baumann A, Croisé-Laurent V, Rio E, Sourd SL, Gustin P, Perret C, Peiffert D, Deutsch E, et al. Hafnium oxide nanoparticles activated by SBRT: a new interventional radiation therapy approach for the treatment of unresectable liver cancers. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 30: iv123-iv124. PMID 32085010 DOI: 10.1093/Annonc/Mdz157.005 |
0.301 |
|
| 2019 |
Hadoux J, Blanchard P, Scoazec JY, Burtin P, Planchard D, Malka D, Berdelou A, Boige V, Duvillard P, Leboulleux S, Faron M, Tselikas L, Deutsch E, Ducreux M, Baudin E. Post Radiation Grade 3 neuroendocrine carcinoma (PRNEC): a new entity? Neuroendocrinology. PMID 31639792 DOI: 10.1159/000504255 |
0.326 |
|
| 2019 |
Kumar T, Schernberg A, Busato F, Laurans M, Fumagalli I, Dumas I, Deutsch E, Haie-Meder C, Chargari C. Correlation between pelvic bone marrow radiation dose and acute hematological toxicity in cervical cancer patients treated with concurrent chemoradiation. Cancer Management and Research. 11: 6285-6297. PMID 31372035 DOI: 10.2147/Cmar.S195989 |
0.331 |
|
| 2019 |
Bayart E, Flacco A, Delmas O, Pommarel L, Levy D, Cavallone M, Megnin-Chanet F, Deutsch E, Malka V. Fast dose fractionation using ultra-short laser accelerated proton pulses can increase cancer cell mortality, which relies on functional PARP1 protein. Scientific Reports. 9: 10132. PMID 31300704 DOI: 10.1038/S41598-019-46512-1 |
0.323 |
|
| 2019 |
Seban RD, Robert C, Dercle L, Yeh R, Dunant A, Reuze S, Schernberg A, Sun R, Mignot F, Terroir M, Schlumberger M, Haie-Meder C, Chargari C, Deutsch E. Increased bone marrow SUVmax on 18F-FDG PET is associated with higher pelvic treatment failure in patients with cervical cancer treated by chemoradiotherapy and brachytherapy. Oncoimmunology. 8: e1574197. PMID 31069132 DOI: 10.1080/2162402X.2019.1574197 |
0.332 |
|
| 2019 |
Bourgier C, Auperin A, Rivera S, Boisselier P, Petit B, Lang P, Lassau N, Taourel P, Tetreau R, Azria D, Bourhis J, Deutsch E, Vozenin MC. Pravastatin Reverses Established Radiation-Induced Cutaneous and Subcutaneous Fibrosis in Patients with Head and Neck Cancer: Results of the Biology-Driven Phase Ii Clinical Trial Pravacur. International Journal of Radiation Oncology, Biology, Physics. PMID 30776452 DOI: 10.1016/J.Ijrobp.2019.02.024 |
0.369 |
|
| 2019 |
Mondini M, Loyher PL, Hamon P, Gerbé De Thoré M, Laviron M, Berthelot K, Clémenson C, Salomon BL, Combadière C, Deutsch E, Boissonnas A. CCR2-dependent recruitment of Tregs and monocytes following radiotherapy is associated with TNFα-mediated resistance. Cancer Immunology Research. PMID 30696630 DOI: 10.1158/2326-6066.Cir-18-0633 |
0.352 |
|
| 2019 |
Bockel S, Escande A, Dumas I, Manea E, Morice P, Gouy S, Deutsch E, Haie-Meder C, Chargari C. Total Reference Air Kerma is Associated with Late Bowel Morbidity in Locally Advanced Cervical Cancer Patients Treated with Image-Guided Adaptive Brachytherapy. Journal of Clinical Medicine. 8. PMID 30669569 DOI: 10.3390/Jcm8010125 |
0.354 |
|
| 2019 |
Loi M, Dunant A, Ghith S, Cascales-Garcia AM, Mazouni C, Pistilli B, Mathieu MC, Deutsch E, Arriagada R, Rivera S. Clinical Response to Induction Chemotherapy Predicts Outcome after Combined-Modality Therapy in Inflammatory Breast Cancer. Cancer Investigation. 1-10. PMID 30656969 DOI: 10.1080/07357907.2018.1564325 |
0.321 |
|
| 2019 |
Chajon E, Pracht M, Baere TD, Bronowicki J, Vendrely V, Baumann A, Valérie L, Rio E, Rolland Y, Sourd SL, Gustin P, Perret C, Mornex F, Peiffert D, Merle P, ... Deutsch E, et al. Hepatocellular carcinoma and liver metastasis treated by hafnium oxide nanoparticles activated by SBRT: A phase I/II trial. Journal of Clinical Oncology. 37: 340-340. DOI: 10.1200/Jco.2019.37.4_Suppl.340 |
0.344 |
|
| 2019 |
Chajon E, Pracht M, Rolland Y, Baere TD, Bronowicki J, Vendrely V, Cunha AS, Baumann A, Valérie L, Rio E, Sourd SL, Gustin P, Perret C, Peiffert D, Deutsch E. First-in-class hafnium oxide nanoparticles NBTXR3 in the treatment of liver cancers. Journal of Clinical Oncology. 37. DOI: 10.1200/Jco.2019.37.15_Suppl.E15642 |
0.301 |
|
| 2019 |
Pracht M, Chajon E, Rolland Y, Baere Td, Nguyen F, Bronowicki J-, Vendrely V, Cunha AS, Baumann A-, Croisé-Laurent V, Rio E, Said P, Sourd SL, Gustin P, Perret C, ... ... Deutsch E, et al. Phase I/II trial of NBTXR3 activated by SBRT in patients with hepatocellular carcinoma or liver metastasis Annals of Oncology. 30. DOI: 10.1093/Annonc/Mdz247.082 |
0.307 |
|
| 2019 |
Ou D, Adam J, Garberis I, Blanchard P, Nguyen F, Levy A, Casiraghi O, Leijenaar RTH, Gorphe P, Breuskin I, Janot F, Robert C, Lambin P, Temam S, Scoazec J, ... Deutsch E, et al. OC-0586 Immunological contexture basis of a prognostic radiomics signature in head and neck cancers Radiotherapy and Oncology. 133. DOI: 10.1016/S0167-8140(19)31006-0 |
0.304 |
|
| 2019 |
Chargari C, Haie-Meder C, Gouy S, Deutsch E. SP-0123 Improving outcomes in high-risk locally advanced cervical cancer: extended field RT, adjuvant chemotherapy or immunotherapy? Radiotherapy and Oncology. 133. DOI: 10.1016/S0167-8140(19)30543-2 |
0.314 |
|
| 2018 |
de Weger VA, de Jonge M, Langenberg MHG, Schellens JHM, Lolkema M, Varga A, Demers B, Thomas K, Hsu K, Tuffal G, Goodstal S, Macé S, Deutsch E. A phase I study of the HDM2 antagonist SAR405838 combined with the MEK inhibitor pimasertib in patients with advanced solid tumours. British Journal of Cancer. PMID 30585255 DOI: 10.1038/S41416-018-0355-8 |
0.302 |
|
| 2018 |
Schernberg A, Mezquita L, Boros A, Botticella A, Caramella C, Besse B, Escande A, Planchard D, Péchoux CL, Deutsch E. Neutrophilia as prognostic biomarker in locally advanced stage III lung cancer. Plos One. 13. PMID 30304046 DOI: 10.1371/Journal.Pone.0204490 |
0.327 |
|
| 2018 |
Loganadane G, Dhermain F, Louvel G, Kauv P, Deutsch E, Le Péchoux C, Levy A. Brain Radiation Necrosis: Current Management With a Focus on Non-small Cell Lung Cancer Patients. Frontiers in Oncology. 8: 336. PMID 30234011 DOI: 10.3389/Fonc.2018.00336 |
0.362 |
|
| 2018 |
Bockel S, Durand B, Deutsch E. Combining radiation therapy and cancer immune therapies: From preclinical findings to clinical applications. Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique. PMID 30197026 DOI: 10.1016/J.Canrad.2018.07.136 |
0.34 |
|
| 2018 |
Ou D, Adam J, Garberis I, Blanchard P, Nguyen F, Levy A, Casiraghi O, Gorphe P, Breuskin I, Janot F, Temam S, Scoazec JY, Deutsch E, Tao Y. Influence of tumor-associated macrophages and HLA class I expression according to HPV status in head and neck cancer patients receiving chemo/bioradiotherapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 30172455 DOI: 10.1016/J.Radonc.2018.08.013 |
0.318 |
|
| 2018 |
Schernberg A, Blanchard P, Chargari C, Ou D, Levy A, Gorphe P, Breuskin I, Atallah S, Caula A, Escande A, Janot F, Nguyen F, Temam S, Deutsch E, Tao Y. Leukocytosis, prognosis biomarker in locally advanced head and neck cancer patients after chemoradiotherapy. Clinical and Translational Radiation Oncology. 12: 8-15. PMID 30073209 DOI: 10.1016/J.Ctro.2018.07.002 |
0.362 |
|
| 2018 |
Reuzé S, Schernberg A, Orlhac F, Sun R, Chargari C, Dercle L, Deutsch E, Buvat I, Robert C. Radiomics in Nuclear Medicine Applied to Radiation Therapy: Methods, Pitfalls, and Challenges. International Journal of Radiation Oncology, Biology, Physics. PMID 30064704 DOI: 10.1016/J.Ijrobp.2018.05.022 |
0.35 |
|
| 2018 |
Schernberg A, Nivet A, Dhermain F, Ammari S, Escande A, Pallud J, Louvel G, Deutsch E. Neutrophilia as a biomarker for overall survival in newly diagnosed high-grade glioma patients undergoing chemoradiation. Clinical and Translational Radiation Oncology. 10: 47-52. PMID 29928705 DOI: 10.1016/J.Ctro.2018.04.002 |
0.322 |
|
| 2018 |
Schernberg A, Bockel S, Annede P, Fumagalli I, Escande A, Mignot F, Kissel M, Morice P, Bentivegna E, Gouy S, Deutsch E, Haie-Meder C, Chargari C. Tumor Shrinkage During Chemoradiation in Locally Advanced Cervical Cancer Patients: Prognostic Significance, and Impact for Image-Guided Adaptive Brachytherapy. International Journal of Radiation Oncology Biology Physics. 102: 362-372. PMID 29920324 DOI: 10.1016/J.Ijrobp.2018.06.014 |
0.363 |
|
| 2018 |
Martins I, Raza SQ, Voisin L, Dakhli H, Allouch A, Law F, Sabino D, De Jong D, Thoreau M, Mintet E, Dugué D, Piacentini M, Gougeon ML, Jaulin F, Bertrand P, ... ... Deutsch E, et al. Anticancer chemotherapy and radiotherapy trigger both non-cell-autonomous and cell-autonomous death. Cell Death & Disease. 9: 716. PMID 29915308 DOI: 10.1038/S41419-018-0747-Y |
0.307 |
|
| 2018 |
Lühr A, von Neubeck C, Pawelke J, Seidlitz A, Peitzsch C, Bentzen SM, Bortfeld T, Debus J, Deutsch E, Langendijk JA, Loeffler JS, Mohan R, Scholz M, Sørensen BS, Weber DC, et al. "Radiobiology of Proton Therapy": Results of an international expert workshop. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 29861141 DOI: 10.1016/J.Radonc.2018.05.018 |
0.316 |
|
| 2018 |
Chargari C, Limbergen EV, Mahantshetty U, Deutsch É, Haie-Méder C. Radiobiology of brachytherapy: The historical view based on linear quadratic model and perspectives for optimization. Cancer Radiotherapie. 22: 312-318. PMID 29858137 DOI: 10.1016/J.Canrad.2017.11.011 |
0.332 |
|
| 2018 |
Bockel S, Vallard A, Lévy A, François S, Bourdis M, Le Gallic C, Riccobono D, Annede P, Drouet M, Tao Y, Blanchard P, Deutsch É, Magné N, Chargari C. Pharmacological modulation of radiation-induced oral mucosal complications. Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique. PMID 29776830 DOI: 10.1016/J.Canrad.2017.11.006 |
0.355 |
|
| 2018 |
Manea E, Escande A, Bockel S, Khettab M, Dumas I, Lazarescu I, Fumagalli I, Morice P, Deutsch E, Haie-Meder C, Chargari C. Risk of Late Urinary Complications Following Image Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer: Refining Bladder Dose-Volume Parameters. International Journal of Radiation Oncology Biology Physics. 101: 411-420. PMID 29559282 DOI: 10.1016/J.Ijrobp.2018.02.004 |
0.325 |
|
| 2018 |
Sun R, Koubaa I, Limkin EJ, Dumas I, Bentivegna E, Castanon E, Gouy S, Baratiny C, Monnot F, Maroun P, Ammari S, Zareski E, Balleyguier C, Deutsch É, Morice P, et al. Locally advanced cervical cancer with bladder invasion: clinical outcomes and predictive factors for vesicovaginal fistulae. Oncotarget. 9: 9299-9310. PMID 29507691 DOI: 10.18632/Oncotarget.24271 |
0.313 |
|
| 2018 |
Louvel G, Bahleda R, Ammari S, Le Péchoux C, Levy A, Massard C, Le Pavec J, Champiat S, Deutsch E. Immunotherapy and pulmonary toxicities: can concomitant immune-checkpoint inhibitors with radiotherapy increase the risk of radiation pneumonitis? The European Respiratory Journal. 51. PMID 29301923 DOI: 10.1183/13993003.01737-2017 |
0.3 |
|
| 2018 |
Chajon E, Pracht M, Baere TD, Bronowicki J, Vendrely V, Baumann A, Croisé-Laurent V, Deutsch E. A phase I/II trial of NBTXR3 nanoparticles activated by SBRT in the treatment of liver cancers. Journal of Clinical Oncology. 36. DOI: 10.1200/Jco.2018.36.4_Suppl.Tps551 |
0.344 |
|
| 2018 |
Sun R, Limkin EJ, Dercle L, Reuzé S, Champiat S, Brandao D, Verlingue L, Ammari S, Aspeslagh S, Hollebecque A, Massard C, Marabelle A, Scoazec J, Robert C, Soria J, ... Deutsch E, et al. Abstract A051: Prediction of clinical outcomes of cancer patients treated with anti-PD-1/PD-L1 using a radiomics-based imaging score of immune infiltrate Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-A051 |
0.32 |
|
| 2018 |
Escande A, Bockel S, Manea E, Schernberg A, Mazeron R, Deutsch E, Dumas I, Morice P, Haie-Meder C, Chargari C. EP-2221: Overweight is associated with pelvic nodal failure after chemoradiation in cervical cancer patients Radiotherapy and Oncology. 127. DOI: 10.1016/S0167-8140(18)32530-1 |
0.305 |
|
| 2018 |
Boros A, Blanchard P, Gorphe P, Breuskin I, Even C, Nguyen F, Deutsch E, Bidault F, Janot F, Temam S, Mirghani H, Tao Y. EP-1158: Prognostic factors and role of neck dissection in N3 head and neck cancers treated with radiotherapy Radiotherapy and Oncology. 127. DOI: 10.1016/S0167-8140(18)31468-3 |
0.305 |
|
| 2018 |
Kumar T, Schernberg A, Busato F, Laurans M, Manea E, Dumas I, Maroun P, Berthold C, Lazarescu I, Deutsch E, Haie-Meder C, Chargari C. PO-0815: Correlation between pelvic bone marrow radiation dose and hematologic toxicity in cervical cancer Radiotherapy and Oncology. 127. DOI: 10.1016/S0167-8140(18)31125-3 |
0.32 |
|
| 2018 |
Bourgier C, Rivera S, Vozenin MC, Boisselier P, Azria D, Lassau N, Taourel P, Bourhis J, Deutsch E, Aupérin A. OC-0486: Pravastatin reverses fibrosis in head and neck cancer patients: phase II clinical trial results Radiotherapy and Oncology. 127. DOI: 10.1016/S0167-8140(18)30796-5 |
0.317 |
|
| 2018 |
Escande A, Bockel S, Khettab M, Manea E, Dumas I, Mazeron R, Schernberg A, Deutsch E, Morice P, Haie-Meder C, Chargari C. PV-0259: Impact of an additional chemotherapy cycle during brachytherapy in cervical cancer patients Radiotherapy and Oncology. 127. DOI: 10.1016/S0167-8140(18)30569-3 |
0.333 |
|
| 2018 |
Reuzé S, Alexis A, Chargari C, Bockel S, Berthelot K, Escande A, Dumas I, Orlhac F, Haie-Meder C, Deutsch E, Robert C. OC-0075: A MRI radiomic signature for predicting brachytherapy outcomes in locally advanced cervical cancer Radiotherapy and Oncology. 127. DOI: 10.1016/S0167-8140(18)30385-2 |
0.302 |
|
| 2018 |
Manea E, Escande A, Bockel S, Busato F, Kumar T, Laurans M, Dumas I, MazeronΥ R, Lazarescu I, Deutsch E, Haie-Meder C, Chargari C. OC-0071: Bladder and bladder trigone dose/volume parameters: correlation with toxicity in cervical cancer Radiotherapy and Oncology. 127: S33. DOI: 10.1016/S0167-8140(18)30381-5 |
0.303 |
|
| 2018 |
Rodriguez EC, Pracht M, Baere TD, Nguyen TVF, Bronowicki JP, Vendrely V, Baumann AS, Croisé-Laurent VV, Rio E, Rolland Y, Sourd SL, Gustin P, Perret C, Mornex F, Peiffert D, ... ... Deutsch E, et al. Hafnium Oxide Nanoparticles Activated By Radiation Therapy: An Innovative Approach for the Treatment of Liver Cancers International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.469 |
0.303 |
|
| 2018 |
Schernberg A, Bockel S, Fumagalli I, Annede P, Escande A, Mignot F, Kissel M, Morice P, Deutsch E, Haie-Meder C, Chargari C. Impact of Tumor Size, Shape and Patterns of Response to Chemoradiation in Locally Advanced Cervical Cancer Patients International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.1733 |
0.33 |
|
| 2018 |
Alexis A, Reuzé S, Bockel S, Berthelot K, Dumas I, Orlhac F, Sun R, Escande A, Ammari S, Haie-Meder C, Chargari C, Deutsch E, Robert C. 28 An MRI radiomic signature for predicting brachytherapy outcomes in locally advanced cervical cancer Physica Medica. 56: 17. DOI: 10.1016/J.Ejmp.2018.09.041 |
0.321 |
|
| 2017 |
Schernberg A, Dhermain F, Ammari S, Dumont SN, Domont J, Patrikidou A, Pallud J, Dezamis É, Deutsch É, Louvel G. Reirradiation with concurrent bevacizumab for recurrent high-grade gliomas in adult patients. Cancer Radiotherapie. 22: 9-16. PMID 29217134 DOI: 10.1016/J.Canrad.2017.06.013 |
0.31 |
|
| 2017 |
Escande A, Maroun P, Dumas I, Schernberg A, Bossi A, Crevoisier RD, Deutsch E, Haie-Meder C, Chargari C. Brachytherapy for conservative treatment of invasive penile carcinoma in older patients: Single institution experience Journal of Geriatric Oncology. 9: 275-278. PMID 29170049 DOI: 10.1016/J.Jgo.2017.11.001 |
0.317 |
|
| 2017 |
Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillère R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, Fidelle M, Flament C, Poirier-Colame V, Opolon P, Klein C, ... ... Deutsch E, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science (New York, N.Y.). PMID 29097494 DOI: 10.1126/Science.Aan3706 |
0.305 |
|
| 2017 |
Bahleda R, Le Deley MC, Bernard A, Chaturvedi S, Hanley M, Poterie A, Gazzah A, Varga A, Touat M, Deutsch E, Massard C, Van De Velde H, Hollebecque A, Sallansonnet-Froment M, Ricard D, et al. Phase I trial of bortezomib daily dose: safety, pharmacokinetic profile, biological effects and early clinical evaluation in patients with advanced solid tumors. Investigational New Drugs. PMID 29094232 DOI: 10.1007/S10637-017-0531-3 |
0.33 |
|
| 2017 |
Ou D, Garberis I, Adam J, Blanchard P, Nguyen F, Levy A, Casiraghi O, Gorphe P, Breuskin I, Janot F, Temam S, Scoazec JY, Deutsch E, Tao Y. Prognostic value of tissue necrosis, hypoxia-related markers and correlation with HPV status in head and neck cancer patients treated with bio- or chemo-radiotherapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 29079308 DOI: 10.1016/J.Radonc.2017.10.007 |
0.34 |
|
| 2017 |
Wu Q, Allouch A, Martins I, Modjtahedi N, Deutsch E, Perfettini JL. Macrophage biology plays a central role during ionizing radiation-elicited tumor response. Biomedical Journal. 40: 200-211. PMID 28918908 DOI: 10.1016/J.Bj.2017.06.003 |
0.335 |
|
| 2017 |
Schernberg A, Reuze S, Orlhac F, Buvat I, Dercle L, Sun R, Limkin E, Escande A, Haie-Meder C, Deutsch E, Chargari C, Robert C. A score combining baseline neutrophilia and primary tumor SUVpeak measured from FDG PET is associated with outcome in locally advanced cervical cancer. European Journal of Nuclear Medicine and Molecular Imaging. PMID 28916879 DOI: 10.1007/S00259-017-3824-Z |
0.327 |
|
| 2017 |
Rivera S, Leteur C, Mégnin F, Law F, Martins I, Kloos I, Depil S, Modjtahedi N, Perfettini JL, Hennequin C, Deutsch E. Time dependent modulation of tumor radiosensitivity by a pan HDAC inhibitor: abexinostat. Oncotarget. 8: 56210-56227. PMID 28915585 DOI: 10.18632/Oncotarget.14813 |
0.342 |
|
| 2017 |
Deutsch E, Moyal EC, Gregorc V, Zucali PA, Menard J, Soria JC, Kloos I, Hsu J, Luan Y, Liu E, Vezan R, Graef T, Rivera S. A phase 1 dose-escalation study of the oral histone deacetylase inhibitor abexinostat in combination with standard hypofractionated radiotherapy in advanced solid tumors. Oncotarget. 8: 56199-56209. PMID 28915584 DOI: 10.18632/Oncotarget.14147 |
0.36 |
|
| 2017 |
Dercle L, Ammari S, Bateson M, Durand PB, Haspinger E, Massard C, Jaudet C, Varga A, Deutsch E, Soria JC, Ferté C. Limits of radiomic-based entropy as a surrogate of tumor heterogeneity: ROI-area, acquisition protocol and tissue site exert substantial influence. Scientific Reports. 7: 7952. PMID 28801575 DOI: 10.1038/S41598-017-08310-5 |
0.314 |
|
| 2017 |
Ou D, Blanchard P, Rosellini S, Levy A, Nguyen F, Leijenaar RTH, Garberis I, Gorphe P, Bidault F, Ferté C, Robert C, Casiraghi O, Scoazec JY, Lambin P, Temam S, ... Deutsch E, et al. Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to Human Papillomavirus status. Oral Oncology. 71: 150-155. PMID 28688683 DOI: 10.1016/J.Oraloncology.2017.06.015 |
0.324 |
|
| 2017 |
Clémenson C, Chargari C, Liu W, Mondini M, Ferté C, Burbridge MF, Cattan V, Jacquet-Bescond A, Deutsch E. The MET/AXL/FGFR inhibitor S49076 impairs Aurora B activity and improves the antitumor efficacy of radiotherapy. Molecular Cancer Therapeutics. PMID 28619752 DOI: 10.1158/1535-7163.Mct-17-0112 |
0.381 |
|
| 2017 |
Wu Q, Allouch A, Martins I, Brenner C, Modjtahedi N, Deutsch E, Perfettini JL. Modulating Both Tumor Cell Death and Innate Immunity Is Essential for Improving Radiation Therapy Effectiveness. Frontiers in Immunology. 8: 613. PMID 28603525 DOI: 10.3389/Fimmu.2017.00613 |
0.355 |
|
| 2017 |
Wu Q, Allouch A, Paoletti A, Leteur C, Mirjolet C, Martins I, Voisin L, Law F, Dakhli H, Mintet E, Thoreau M, Muradova Z, Gauthier M, Caron O, Milliat F, ... ... Deutsch E, et al. NOX2-dependent ATM kinase activation dictates pro-inflammatory macrophage phenotype and improves effectiveness to radiation therapy. Cell Death and Differentiation. PMID 28574504 DOI: 10.1038/Cdd.2017.91 |
0.305 |
|
| 2017 |
Mazeron R, Gouy S, Escande A, Dumas I, Campo ERd, Bentivegna E, Bacorro W, Lefkopoulos D, Deutsch E, Morice P, Haie-Meder C, Chargari C. Locally advanced cervical cancer: Is it relevant to report image-guided adaptive brachytherapy using point A dose? Brachytherapy. 16: 862-869. PMID 28551312 DOI: 10.1016/J.Brachy.2017.04.244 |
0.338 |
|
| 2017 |
Del Campo ER, Rivera S, Martínez-Paredes M, Hupé P, Escarpa AS, Borget I, Mazeron R, Scholl S, Eito AP, Haie-Meder C, Chargari C, Deutsch E. Assessment of the novel online delineation workshop dummy run approach using FALCON within a European multicentre trial in cervical cancer (RAIDs). Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 28532608 DOI: 10.1016/J.Radonc.2017.05.008 |
0.309 |
|
| 2017 |
Escande A, Haie-Meder C, Mazeron R, Maroun P, Cavalcanti A, Crevoisier Rd, Schernberg A, Marsolat F, Blanchard P, Martinetti F, Bossi A, Dumas I, Deutsch E, Chargari C. Brachytherapy for conservative treatment of invasive penile carcinoma: Prognostic factors and long-term analysis of outcome International Journal of Radiation Oncology Biology Physics. 99: 563-570. PMID 28501419 DOI: 10.1016/J.Ijrobp.2017.02.090 |
0.34 |
|
| 2017 |
Boros A, Lacroix L, Lacas B, Adam J, Pignon JP, Caramella C, Planchard D, de Montpreville V, Deutsch E, Levy A, Besse B, Le Pechoux C. Prognostic value of tumor mutations in radically treated locally advanced non-small cell lung cancer patients. Oncotarget. 8: 25189-25199. PMID 28445990 DOI: 10.18632/Oncotarget.15966 |
0.347 |
|
| 2017 |
Massard C, Michiels S, Ferté C, Le Deley MC, Lacroix L, Hollebecque A, Verlingue L, Ileana E, Rosellini S, Ammari S, Ngo-Camus M, Bahleda R, Gazzah A, Varga A, Postel-Vinay S, ... ... Deutsch E, et al. High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial. Cancer Discovery. PMID 28365644 DOI: 10.1158/2159-8290.Cd-16-1396 |
0.345 |
|
| 2017 |
Felefly T, Mazeron R, Huertas A, Canova CH, Maroun P, Kordahi M, Morice P, Deutsch É, Haie-Méder C, Chargari C. Pelvic radiotherapy in the setting of rheumatoid arthritis: Refining the paradigm Cancer Radiotherapie. 21: 109-113. PMID 28363728 DOI: 10.1016/J.Canrad.2016.09.020 |
0.354 |
|
| 2017 |
Annede P, Seisen T, Klotz C, Mazeron R, Maroun P, Petit C, Deutsch E, Bossi A, Haie-Meder C, Chargari C, Blanchard P. Inflammatory bowel diseases activity in patients undergoing pelvic radiation therapy. Journal of Gastrointestinal Oncology. 8: 173-179. PMID 28280621 DOI: 10.21037/Jgo.2017.01.13 |
0.301 |
|
| 2017 |
Levy A, Nigro G, Sansonetti PJ, Deutsch E. Candidate immune biomarkers for radioimmunotherapy. Biochimica Et Biophysica Acta. PMID 28254528 DOI: 10.1016/J.Bbcan.2017.02.006 |
0.317 |
|
| 2017 |
Annede P, Gouy S, Mazeron R, Bentivegna E, Maroun P, Petit C, Dumas I, Leary A, Genestie C, Lhommé C, Deutsch E, Morice P, Pautier P, Haie-Meder C, Chargari C. Optimizing Local Control in High-Grade Uterine Sarcoma: Adjuvant Vaginal Vault Brachytherapy as Part of a Multimodal Treatment. The Oncologist. PMID 28174295 DOI: 10.1634/Theoncologist.2016-0204 |
0.326 |
|
| 2017 |
Vũ Bezin J, Allodji RS, Mège JP, Beldjoudi G, Saunier F, Chavaudra J, Deutsch E, de Vathaire F, Bernier V, Carrie C, Lefkopoulos D, Diallo I. A review of uncertainties in radiotherapy dose reconstruction and their impacts on dose-response relationships. Journal of Radiological Protection : Official Journal of the Society For Radiological Protection. 37: R1-R18. PMID 28118156 DOI: 10.1088/1361-6498/Aa575D |
0.304 |
|
| 2017 |
Espenel S, Vallard A, Rancoule C, Garcia MA, Guy JB, Chargari C, Deutsch E, Magné N. Melanoma: Last call for radiotherapy. Critical Reviews in Oncology/Hematology. 110: 13-19. PMID 28109401 DOI: 10.1016/J.Critrevonc.2016.12.003 |
0.375 |
|
| 2017 |
Schernberg A, Moureau-Zabotto L, Rivin Del Campo E, Escande A, Ducreux M, Nguyen F, Goere D, Chargari C, Deutsch E. Leukocytosis and neutrophilia predict outcome in locally advanced esophageal cancer treated with definitive chemoradiation. Oncotarget. PMID 28086222 DOI: 10.18632/Oncotarget.14584 |
0.342 |
|
| 2017 |
Mondini M, Loyher PL, Berthelot K, Clémenson C, Boissonnas A, Deutsch E. Abstract 5668: CCL2/CCR2-driven monocyte recruitment to the tumor following radiotherapy influences the outcome of the treatment of head and neck cancer Cancer Research. 77: 5668-5668. DOI: 10.1158/1538-7445.Am2017-5668 |
0.386 |
|
| 2017 |
Chargari C, Escande A, Haie-Meder C, Maroun P, Gouy S, Mazeron R, Leroy T, Bentivegna E, Morice P, Deutsch E. EP-1285: Neutrophilia in locally advanced cervical cancer: biomarker for image-guided adaptive brachytherapy? Radiotherapy and Oncology. 123. DOI: 10.1016/S0167-8140(17)31720-6 |
0.309 |
|
| 2017 |
Ou D, Adam J, Garberis I, Blanchard P, Nguyen F, Levy A, Casiraghi O, Gorphe P, Breuskin I, Janot F, Temam S, Scoazec JY, Deutsch E, Tao Y. Clinical Relevance of Tumor Infiltrating Lymphocytes, PD-L1 Expression, and Correlation with HPV/P16 in Head and Neck Cancer Treated with Bio- or Chemoradiation Therapy International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.505 |
0.317 |
|
| 2017 |
Bourgier C, Rivera S, Vozenin MC, Boisselier P, Azria D, Lassau N, Taourel P, Ollivier N, Abou-Lavergne A, Bourhis J, Deutsch E, Auperin A. Pravastatin Reverses Established Radiation-Induced Cutaneous and Subcutaneous Fibrosis in Head and Neck Cancer Patients: Results of a Biology-Driven Clinical Trial, Pravacur Phase 2 International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.180 |
0.364 |
|
| 2017 |
Schernberg A, Reuze S, Robert C, Sun R, Limkin E, Buvat I, Orlhac F, Dercle L, Escande A, Haie-Meder C, Deutsch E, Chargari C. A Score Combining SUV peak of the Primary Tumor Computed on Pretreatment FDG-PET Scans and Neutrophilia Predicts Outcome in Locally Advanced Cervical Cancer International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.1345 |
0.301 |
|
| 2017 |
Ou D, Blanchard P, Rosellini S, Levy A, Nguyen F, Leijenaar R, Garberis I, Gorphe P, Bidault F, Ferte C, Robert C, Casiraghi O, Scoazec JY, Lambin P, Temam S, ... Deutsch E, et al. Predictive and Prognostic Value of CT Based Radiomics Signature in Head and Neck Squamous Cell Carcinoma Patients Treated With Concurrent Chemoradiation Therapy or Bioradiation Therapy and Its Added Value to Human Papillomavirus Status International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.047 |
0.302 |
|
| 2016 |
Schernberg A, Escande A, Rivin Del Campo E, Ducreux M, Nguyen F, Goere D, Chargari C, Deutsch E. Leukocytosis and neutrophilia predicts outcome in anal cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 28024835 DOI: 10.1016/J.Radonc.2016.12.009 |
0.344 |
|
| 2016 |
Bonvalot S, Le Pechoux C, De Baere T, Kantor G, Buy X, Stoeckle E, Terrier P, Sargos P, Coindre JM, Lassau N, Ait Sarkouh R, Dimitriu M, Borghi E, Levy L, Deutsch E, et al. First-in-Human Study Testing a New Radioenhancer Using Nanoparticles (NBTXR3) Activated by Radiation Therapy in Patients with Locally Advanced Soft Tissue Sarcomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27998887 DOI: 10.1158/1078-0432.Ccr-16-1297 |
0.313 |
|
| 2016 |
Ou D, Blanchard P, El Khoury C, De Felice F, Even C, Levy A, Nguyen F, Janot F, Gorphe P, Deutsch E, Temam S, Tao Y. Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by concurrent chemoradiotherapy or chemoradiotherapy alone in locally advanced non-endemic nasopharyngeal carcinoma. Oral Oncology. 62: 114-121. PMID 27865364 DOI: 10.1016/J.Oraloncology.2016.10.011 |
0.316 |
|
| 2016 |
Escande A, Haie-Meder C, Maroun P, Gouy S, Mazeron R, Leroy T, Bentivegna E, Morice P, Deutsch E, Chargari C. Neutrophilia in locally advanced cervical cancer: A novel biomarker for image-guided adaptive brachytherapy? Oncotarget. 7: 74886-74894. PMID 27713124 DOI: 10.18632/Oncotarget.12440 |
0.386 |
|
| 2016 |
Rancoule C, Vallard A, Espenel S, Guy JB, Xia Y, El Meddeb Hamrouni A, Rodriguez-Lafrasse C, Chargari C, Deutsch E, Magné N. Immunotherapy in head and neck cancer: Harnessing profit on a system disruption. Oral Oncology. PMID 27623508 DOI: 10.1016/J.Oraloncology.2016.09.002 |
0.365 |
|
| 2016 |
Bowles DW, Deutsch E, Raben D. Successes and Failures of Combined Modality Therapies in Head and Neck Cancer. Seminars in Radiation Oncology. 26: 299-306. PMID 27619251 DOI: 10.1016/J.Semradonc.2016.05.004 |
0.359 |
|
| 2016 |
Escande A, Mazeron R, Gouy S, Bentivegna E, Maroun P, Fahra G, Oberlander A, Dumas I, Castelnau-Marchand P, Deutsch E, Morice P, Haie-Meder C, Chargari C. Preoperative image-guided brachytherapy in early stage cervical cancers. Radiotherapy and Oncology. 120: 455-459. PMID 27614680 DOI: 10.1016/J.Radonc.2016.07.003 |
0.332 |
|
| 2016 |
Antoni D, Bockel S, Deutsch E, Mornex F. Radiothérapie et thérapies ciblées/immunothérapie Cancer Radiotherapie. 20: 434-441. PMID 27614521 DOI: 10.1016/J.Canrad.2016.07.082 |
0.339 |
|
| 2016 |
Chargari C, Mazeron R, Dunant A, Gouy S, Petit C, Maroun P, Uzan C, Annede P, Bentivegna E, Balleyguier C, Genestie C, Pautier P, Leary A, Lhomme C, Deutsch E, et al. Impact of primary para-aortic lymphadenectomy on distant failure in locally advanced cervical cancer patients treated in the era of image-guided adaptive brachytherapy. Clinical & Experimental Metastasis. PMID 27530648 DOI: 10.1007/S10585-016-9817-7 |
0.333 |
|
| 2016 |
Levy A, Chargari C, Marabelle A, Perfettini JL, Magné N, Deutsch E. Can immunostimulatory agents enhance the abscopal effect of radiotherapy? European Journal of Cancer (Oxford, England : 1990). 62: 36-45. PMID 27200491 DOI: 10.1016/J.Ejca.2016.03.067 |
0.326 |
|
| 2016 |
Chargari C, Mazeron R, Escande A, Maroun P, Dumas I, Martinetti F, Tafo-Guemnie A, Deutsch E, Morice P, Haie-Meder C. Image-guided adaptive brachytherapy in cervical cancer: Patterns of relapse by brachytherapy planning parameters. Brachytherapy. PMID 27180129 DOI: 10.1016/J.Brachy.2016.04.006 |
0.341 |
|
| 2016 |
Deutsch E, Haie-Meder C, Bayar MA, Mondini M, Laporte M, Mazeron R, Adam J, Varga A, Vassal G, Magné N, Chargari C, Lanoy E, Pautier P, Levy A, Soria JC. Phase I trial evaluating the antiviral agent Cidofovir in combination with chemoradiation in cervical cancer patients. Oncotarget. PMID 27016411 DOI: 10.18632/Oncotarget.8224 |
0.383 |
|
| 2016 |
Chargari C, Magne N, Guy JB, Rancoule C, Levy A, Goodman KA, Deutsch E. Optimize and refine therapeutic index in radiation therapy: Overview of a century. Cancer Treatment Reviews. 45: 58-67. PMID 26986027 DOI: 10.1016/J.Ctrv.2016.03.001 |
0.375 |
|
| 2016 |
Chargari C, Goodman KA, Diallo I, Guy JB, Rancoule C, Cosset JM, Deutsch E, Magne N. Risk of second cancers in the era of modern radiation therapy: does the risk/benefit analysis overcome theoretical models? Cancer Metastasis Reviews. PMID 26970966 DOI: 10.1007/S10555-016-9616-2 |
0.35 |
|
| 2016 |
Rivoirard R, Vallard A, Langrand-Escure J, Ben Mrad M, Wang G, Guy JB, Diao P, Dubanchet A, Deutsch E, Rancoule C, Magne N. Thirty years of phase I radiochemotherapy trials: Latest development. European Journal of Cancer (Oxford, England : 1990). 58: 1-7. PMID 26922167 DOI: 10.1016/J.Ejca.2016.01.012 |
0.366 |
|
| 2016 |
Dhermain F, Deutsch E. Stereotactic radiation and checkpoint inhibitors in melanoma patients with BM: a question of drug, timing or both? Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. PMID 26782954 DOI: 10.1093/Annonc/Mdw001 |
0.332 |
|
| 2016 |
Saleh K, Michot J, Danu A, Lazarovici J, Khalifé-Saleh N, Ghez D, Chahine C, Dakdouki Y, Fahri J, Willekens C, Boros A, Arfi-Rouche J, Maroun P, Deutsch E, Ribrag V, et al. Repetitive Low-Dose Radiation Therapies As an Alternative Option for Indolent Non-Hodgkin Lymphoma Blood. 128: 1784-1784. DOI: 10.1182/Blood.V128.22.1784.1784 |
0.364 |
|
| 2016 |
Yang E, William W, Fayette J, Zhang W, Fink A, Lin AB, Deutsch E. Phase 1b trial of LY2606368 in combination with chemoradiation in patients with locally advanced head and neck squamous cell cancer Annals of Oncology. 27. DOI: 10.1093/Annonc/Mdw376.71 |
0.347 |
|
| 2016 |
Limkin EJC, Schernberg A, Reuze S, Behar L, Ou D, Tao YG, Deutsch E, Robert C, Ferte C. An advanced tumor shape radiomic signature predicts recurrence of locally advanced (LA) HNSCC patients (pts) Annals of Oncology. 27. DOI: 10.1093/Annonc/Mdw376.35 |
0.313 |
|
| 2016 |
Chargari C, Mazeron R, Maroun P, Dumas I, Martinetti F, Tafo-Guemnie A, Deutsch E, Morice P, Haie-Meder C. PO-0958: Locally advanced cervical cancer treated with IGABT: impact of the D90 HR-CTV on patterns of relapse Radiotherapy and Oncology. 119. DOI: 10.1016/S0167-8140(16)32208-3 |
0.307 |
|
| 2016 |
Escande A, Chargari C, Maroun P, Mazeron R, Dumas I, Castelnau-Marchand P, Fahra G, Gouy S, Morice P, Deutsch E, Haie-Meder C. Outcome of Patients with Early-Stage Cervical Cancer Treated with Preoperative Image-Guided Pulse-Dose Rate Brachytherapy Followed by Surgery Brachytherapy. 15. DOI: 10.1016/J.Brachy.2016.04.222 |
0.313 |
|
| 2015 |
Ngo C, Samuels S, Bagrintseva K, Slocker A, Hupé P, Kenter G, Popovic M, Samet N, Tresca P, von der Leyen H, Deutsch E, Rouzier R, Belin L, Kamal M, Scholl S, et al. From prospective biobanking to precision medicine: BIO-RAIDs - an EU study protocol in cervical cancer. Bmc Cancer. 15: 842. PMID 26531748 DOI: 10.1186/S12885-015-1801-0 |
0.311 |
|
| 2015 |
Bahleda R, Hollebecque A, Varga A, Gazzah A, Massard C, Deutsch E, Amellal N, Farace F, Ould-Kaci M, Roux F, Marzin K, Soria JC. Phase I study of afatinib combined with nintedanib in patients with advanced solid tumours. British Journal of Cancer. 113: 1413-20. PMID 26512876 DOI: 10.1038/Bjc.2015.374 |
0.308 |
|
| 2015 |
Haddy N, Diallo S, El-Fayech C, Schwartz B, Pein F, Hawkins M, Veres C, Oberlin O, Guibout C, Pacquement H, Munzer M, N'Guyen TD, Bondiau PY, Berchery D, Laprie A, ... ... Deutsch E, et al. Cardiac Diseases Following Childhood Cancer Treatment: Cohort Study. Circulation. PMID 26487757 DOI: 10.1161/Circulationaha.115.016686 |
0.321 |
|
| 2015 |
Mirghani H, Amen F, Tao Y, Deutsch E, Levy A. Increased radiosensitivity of HPV-positive head and neck cancers: Molecular basis and therapeutic perspectives. Cancer Treatment Reviews. PMID 26476574 DOI: 10.1016/J.Ctrv.2015.10.001 |
0.313 |
|
| 2015 |
Allodji RS, Schwartz B, Veres C, Haddy N, Rubino C, Le Deley MC, Labbé M, Diop F, Jackson A, Dayet F, Benabdennebi A, Llanas D, Vu Bezin J, Chavaudra J, Lefkopoulos D, ... Deutsch E, et al. Risk of Subsequent Leukemia After a Solid Tumor in Childhood: Impact of Bone Marrow Radiation Therapy and Chemotherapy. International Journal of Radiation Oncology, Biology, Physics. 93: 658-67. PMID 26461008 DOI: 10.1016/J.Ijrobp.2015.07.2270 |
0.338 |
|
| 2015 |
Lazaropoulos M, Dong Y, Clark E, Greeley NR, Seyer LA, Brigatti KW, Christie C, Perlman SL, Wilmot GR, Gomez CM, Mathews KD, Yoon G, Zesiewicz T, Hoyle C, Subramony SH, ... ... Deutsch EC, et al. Frataxin levels in peripheral tissue in Friedreich ataxia. Annals of Clinical and Translational Neurology. 2: 831-42. PMID 26339677 DOI: 10.1002/Acn3.225 |
0.354 |
|
| 2015 |
de Vathaire F, Haddy N, Allodji RS, Hawkins M, Guibout C, El-Fayech C, Teinturier C, Oberlin O, Pacquement H, Diop F, Kalhouche A, Benadjaoud M, Winter D, Jackson A, Bezin Mai-Quynh G, ... ... Deutsch E, et al. Thyroid Radiation Dose and Other Risk Factors of Thyroid Carcinoma Following Childhood Cancer. The Journal of Clinical Endocrinology and Metabolism. 100: 4282-90. PMID 26327481 DOI: 10.1210/Jc.2015-1690 |
0.319 |
|
| 2015 |
Worth AJ, Basu SS, Deutsch EC, Hwang WT, Snyder NW, Lynch DR, Blair IA. Stable isotopes and LC-MS for monitoring metabolic disturbances in Friedreich's ataxia platelets. Bioanalysis. 7: 1843-55. PMID 26295986 DOI: 10.4155/Bio.15.118 |
0.333 |
|
| 2015 |
Deutsch É, Lévy A, Chargari C. [Radiation therapy and immunomodulation: Focus on experimental data]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 19: 515-8. PMID 26293415 DOI: 10.1016/J.Canrad.2015.05.018 |
0.327 |
|
| 2015 |
Peyraga G, Capitain O, Rousseau D, Rio E, Septans AL, Baton O, Marquis A, Trémolières P, Gustin P, Ménager É, Branger F, Bressolette M, Deutsch É, Paumier A. [Are extensive fields useful for radiotherapy of oesophageal cancer?]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 19: 313-21. PMID 26232314 DOI: 10.1016/J.Canrad.2015.03.011 |
0.334 |
|
| 2015 |
Schick U, Kyula J, Barker H, Patel R, Zaidi S, Gregory C, Hafsi H, Roulstone V, Deutsch E, McLaughlin M, Harrington K. Trametinib radiosensitises RAS- and BRAF-mutated melanoma by perturbing cell cycle and inducing senescence. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 26163092 DOI: 10.1016/J.Radonc.2015.06.026 |
0.32 |
|
| 2015 |
Rivera S, Louvel G, Rivin Del Campo E, Boros A, Oueslati H, Deutsch É. [Prophylactic axillary radiotherapy for breast cancer]. Cancer RadiothéRapie : Journal De La SociéTé FrançAise De RadiothéRapie Oncologique. 19: 253-60. PMID 26044178 DOI: 10.1016/J.Canrad.2015.05.001 |
0.313 |
|
| 2015 |
Dos Santos MA, Pignon JP, Blanchard P, Lefeuvre D, Levy A, Touat M, Louvel G, Dhermain F, Soria JC, Deutsch E, Le Teuff G. Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survival. Journal of Neuro-Oncology. 123: 307-14. PMID 25975195 DOI: 10.1007/S11060-015-1802-5 |
0.331 |
|
| 2015 |
Levy A, De Felice F, Bellefqih S, Guigay J, Deutsch E, Nguyen F, Blanchard P, Tao Y. Toxicity of concomitant cetuximab and radiotherapy with or without initial taxane-based induction chemotherapy in locally advanced head and neck cancer. Head & Neck. PMID 25974356 DOI: 10.1002/Hed.24125 |
0.345 |
|
| 2015 |
Mondini M, Nizard M, Tran T, Mauge L, Loi M, Clémenson C, Dugue D, Maroun P, Louvet E, Adam J, Badoual C, Helley D, Dransart E, Johannes L, Vozenin MC, ... ... Deutsch E, et al. Synergy of Radiotherapy and a Cancer Vaccine for the Treatment of HPV-Associated Head and Neck Cancer. Molecular Cancer Therapeutics. 14: 1336-45. PMID 25833837 DOI: 10.1158/1535-7163.Mct-14-1015 |
0.345 |
|
| 2015 |
Levy A, Azria D, Pignon JP, Delarochefordiere A, Martel-Lafay I, Rio E, Malka D, Conroy T, Miglianico L, Becouarn Y, Malekzadeh K, Leclercq J, Juzyna B, Ezra P, Lemanski C, ... Deutsch E, et al. Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: long-term results of the UNICANCER ACCORD 16 phase II trial. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 114: 415-6. PMID 25769380 DOI: 10.1016/J.Radonc.2015.02.008 |
0.325 |
|
| 2015 |
Deutsch E, Le Péchoux C, Faivre L, Rivera S, Tao Y, Pignon JP, Angokai M, Bahleda R, Deandreis D, Angevin E, Hennequin C, Besse B, Levy A, Soria JC. Phase I trial of everolimus in combination with thoracic radiotherapy in non-small-cell lung cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 26: 1223-9. PMID 25701455 DOI: 10.1093/Annonc/Mdv105 |
0.349 |
|
| 2015 |
Arshad A, Deutsch E, Vozenin MC. Simultaneous irradiation of fibroblasts and carcinoma cells repress the secretion of soluble factors able to stimulate carcinoma cell migration. Plos One. 10: e0115447. PMID 25635683 DOI: 10.1371/Journal.Pone.0115447 |
0.331 |
|
| 2015 |
Clémenson C, Chargari C, Mondini M, Ferté C, Liu W, Burbridge M, Cattan V, Jacquet-Bescond A, Deutsch E. Abstract 2568: S49076, a MET, AXL, FGFR inhibitor, potentiates radiation therapy in subcutaneous and orthotopic models of lung cancer Cancer Research. 75: 2568-2568. DOI: 10.1158/1538-7445.Am2015-2568 |
0.354 |
|
| 2015 |
Deutsch E, Chargari C. Abstract PL07-02: Tumor hypoxia and radiation resistance: Anything new on the horizon? Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-Pl07-02 |
0.354 |
|
| 2015 |
Boros A, Lacroix L, Lacas B, Adam J, Pignon JP, Caramella C, Planchard D, Levy A, Montpreville V, Deutsch E, Besse B, Pechoux CL. 3000 Chemo-radiation (CRT) and mutation profile in stage III Non Small Cell Lung Cancer (NSCLC): An analysis of the prognostic value European Journal of Cancer. 51. DOI: 10.1016/S0959-8049(15)30056-3 |
0.316 |
|
| 2014 |
Deutsch E, Levy A, Rivera S. 140INDESIGN OF CLINICAL TRIALS INTEGRATING LOCAL TREATMENTS WITH SYSTEMIC THERAPY FOR M1 DISEASE. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 25: iv49. PMID 28170648 DOI: 10.1093/Annonc/Mdu322.2 |
0.383 |
|
| 2014 |
Benadjaoud MA, Blanchard P, Schwartz B, Champoudry J, Bouaita R, Lefkopoulos D, Deutsch E, Diallo I, Cardot H, de Vathaire F. Functional data analysis in NTCP modeling: a new method to explore the radiation dose-volume effects. International Journal of Radiation Oncology, Biology, Physics. 90: 654-63. PMID 25304951 DOI: 10.1016/J.Ijrobp.2014.07.008 |
0.31 |
|
| 2014 |
Jacob J, Nguyen F, Deutsch E, Mornex F. [Stereotactic body radiation therapy in the management of liver tumours]. Cancer Radiothã©Rapie : Journal De La Sociã©Tã© Franã§Aise De Radiothã©Rapie Oncologique. 18: 486-94. PMID 25195113 DOI: 10.1016/J.Canrad.2014.07.145 |
0.337 |
|
| 2014 |
Sole CV, Calvo FA, Serrano J, Del Valle E, Rodriguez M, Muñoz-Calero A, Turégano F, García-Sabrido JL, Garcia-Alfonso P, Peligros I, Rivera S, Deutsch E, Alvarez E. Post-chemoradiation intraoperative electron-beam radiation therapy boost in resected locally advanced rectal cancer: long-term results focused on topographic pattern of locoregional relapse. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 112: 52-8. PMID 24997989 DOI: 10.1016/J.Radonc.2014.05.012 |
0.346 |
|
| 2014 |
Sancey L, Lux F, Kotb S, Roux S, Dufort S, Bianchi A, Crémillieux Y, Fries P, Coll JL, Rodriguez-Lafrasse C, Janier M, Dutreix M, Barberi-Heyob M, Boschetti F, Denat F, ... ... Deutsch E, et al. The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy. The British Journal of Radiology. 87: 20140134. PMID 24990037 DOI: 10.1259/Bjr.20140134 |
0.311 |
|
| 2014 |
Baroudjian B, Boussemart L, Routier E, Dreno B, Tao Y, Deutsch E, Blanchard P, Dhermain F, Vilcot L, Vagner S, Eggermont A, Mateus C, Robert C. Dramatic response to radiotherapy combined with vemurafenib. Is vemurafenib a radiosensitizer? European Journal of Dermatology : Ejd. 24: 265-7. PMID 24721778 DOI: 10.1684/Ejd.2014.2300 |
0.334 |
|
| 2014 |
Monceau V, Llach A, Azria D, Bridier A, Petit B, Mazevet M, Strup-Perrot C, To TH, Calmels L, Germaini MM, Gourgou S, Fenoglietto P, Bourgier C, Gomez AM, Escoubet B, ... ... Deutsch E, et al. Epac contributes to cardiac hypertrophy and amyloidosis induced by radiotherapy but not fibrosis. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 111: 63-71. PMID 24721545 DOI: 10.1016/J.Radonc.2014.01.025 |
0.308 |
|
| 2014 |
Levy A, Blanchard P, Bellefqih S, Brahimi N, Guigay J, Janot F, Temam S, Bourhis J, Deutsch E, Daly-Schveitzer N, Tao Y. Concurrent use of cisplatin or cetuximab with definitive radiotherapy for locally advanced head and neck squamous cell carcinomas. Strahlentherapie Und Onkologie : Organ Der Deutschen RöNtgengesellschaft ... [Et Al]. 190: 823-31. PMID 24638267 DOI: 10.1007/S00066-014-0626-0 |
0.305 |
|
| 2014 |
Deutsch EC, Oglesbee D, Greeley NR, Lynch DR. Usefulness of frataxin immunoassays for the diagnosis of Friedreich ataxia. Journal of Neurology, Neurosurgery, and Psychiatry. 85: 994-1002. PMID 24463479 DOI: 10.1136/Jnnp-2013-306788 |
0.467 |
|
| 2014 |
Sourisseau T, Hassan KA, Wistuba I, Penault-Llorca F, Adam J, Deutsch E, Soria JC. Lung cancer stem cell: fancy conceptual model of tumor biology or cornerstone of a forthcoming therapeutic breakthrough? Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: 7-17. PMID 24346089 DOI: 10.1097/Jto.0000000000000028 |
0.344 |
|
| 2014 |
Bahleda R, Deley ML, Bernard A, Chaturvedi S, Gazzah A, Varga A, Keung C, Deutsch E, Massard C, Velde HVD, Hollebecque A, Angevin E, Ribrag V, Soria J. Phase I trial of bortezomib daily dose: Safety, pharmacokinetic profile, biological effects, and early clinical evaluation in patients with advanced solid tumors. Journal of Clinical Oncology. 32: 2623-2623. DOI: 10.1200/Jco.2014.32.15_Suppl.2623 |
0.309 |
|
| 2014 |
Bonvalot S, Pechoux CL, Baere TD, Buy X, Italiano A, Stockle E, Terrier P, Lassau N, Cesne AL, Sargos P, Antoine M, Lezghed N, Azzouz F, Goberna A, Levy L, ... ... Deutsch E, et al. Phase I study of NBTXR3 nanoparticles, in patients with advanced soft tissue sarcoma (STS). Journal of Clinical Oncology. 32: 10563-10563. DOI: 10.1200/Jco.2014.32.15_Suppl.10563 |
0.337 |
|
| 2014 |
Ferté C, Massard C, Ileana E, Hollebecque A, Lacroix L, Ammari S, Ngo-Camus M, Bahleda R, Gazzah A, Varga A, Postel-Vinay S, Loriot Y, Auger N, Koubi-Pick V, Job B, ... ... deutsch e, et al. Abstract CT240: Molecular screening for cancer treatment optimization (MOSCATO 01): a prospective molecular triage trial; Interim analysis of 420 patients Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Ct240 |
0.346 |
|
| 2014 |
Deutsch E, Levy A, Mazeron R, Gazzah A, Angevin EA, Ribrag V, Balheda R, Varga A, Lhomme C, Haie-Meder C, Soria JC. 219 Phase I trial evaluating the antiviral agent Cidofovir in combination with chemoradiation in cervical cancer patients: A novel approach to treat HPV related malignancies? European Journal of Cancer. 50: 74. DOI: 10.1016/S0959-8049(14)70345-4 |
0.314 |
|
| 2013 |
Basu SS, Deutsch EC, Schmaier AA, Lynch DR, Blair IA. Human platelets as a platform to monitor metabolic biomarkers using stable isotopes and LC-MS. Bioanalysis. 5: 3009-21. PMID 24320127 DOI: 10.4155/Bio.13.269 |
0.431 |
|
| 2013 |
Hollebecque A, Deutsch E, Massard C, Gomez-Roca C, Bahleda R, Ribrag V, Bourgier C, Lazar V, Lacroix L, Gazzah A, Varga A, de Baere T, Beier F, Kroesser S, Trang K, et al. A phase I, dose-escalation study of the Eg5-inhibitor EMD 534085 in patients with advanced solid tumors or lymphoma. Investigational New Drugs. 31: 1530-8. PMID 24077982 DOI: 10.1007/S10637-013-0026-9 |
0.312 |
|
| 2013 |
Deutsch E, Lemanski C, Pignon JP, Levy A, Delarochefordiere A, Martel-Lafay I, Rio E, Malka D, Conroy T, Miglianico L, Becouarn Y, Malekzadeh K, Paris E, Juzyna B, Ezra P, et al. Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trial. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 24: 2834-8. PMID 24026540 DOI: 10.1093/Annonc/Mdt368 |
0.343 |
|
| 2013 |
Chargari C, Riet F, Mazevet M, Morel E, Lepechoux C, Deutsch E. Complications of thoracic radiotherapy. Presse MéDicale (Paris, France : 1983). 42: e342-51. PMID 23972736 DOI: 10.1016/J.Lpm.2013.06.012 |
0.368 |
|
| 2013 |
Oglesbee D, Kroll C, Gakh O, Deutsch EC, Lynch DR, Gavrilova R, Tortorelli S, Raymond K, Gavrilov D, Rinaldo P, Matern D, Isaya G. High-throughput immunoassay for the biochemical diagnosis of Friedreich ataxia in dried blood spots and whole blood. Clinical Chemistry. 59: 1461-9. PMID 23838345 DOI: 10.1373/Clinchem.2013.207472 |
0.349 |
|
| 2013 |
Levy A, Gomez-Roca C, Massard C, Planchard D, Albiges L, Bahleda R, Bourgier C, Deutsch E, Soria JC, Besse B. Clinical benefit for patients with non-small cell lung cancer enrolled in phase I trials. Onkologie. 36: 357-62. PMID 23774150 DOI: 10.1159/000351257 |
0.337 |
|
| 2013 |
Plasterer HL, Deutsch EC, Belmonte M, Egan E, Lynch DR, Rusche JR. Development of frataxin gene expression measures for the evaluation of experimental treatments in Friedreich's ataxia. Plos One. 8: e63958. PMID 23691127 DOI: 10.1371/Journal.Pone.0063958 |
0.463 |
|
| 2013 |
Bibault JE, Fumagalli I, Ferté C, Chargari C, Soria JC, Deutsch E. Personalized radiation therapy and biomarker-driven treatment strategies: a systematic review. Cancer Metastasis Reviews. 32: 479-92. PMID 23595306 DOI: 10.1007/S10555-013-9419-7 |
0.356 |
|
| 2013 |
Chargari C, Clemenson C, Martins I, Perfettini JL, Deutsch E. Understanding the functions of tumor stroma in resistance to ionizing radiation: emerging targets for pharmacological modulation. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 16: 10-21. PMID 23434004 DOI: 10.1016/J.Drup.2013.01.001 |
0.322 |
|
| 2013 |
Heukelom J, Hamming O, Bartelink H, Hoebers F, Giralt J, Herlestam T, Verheij M, van den Brekel M, Vogel W, Slevin N, Deutsch E, Sonke JJ, Lambin P, Rasch C. Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer. Bmc Cancer. 13: 84. PMID 23433435 DOI: 10.1186/1471-2407-13-84 |
0.389 |
|
| 2013 |
Malouf GG, Casiraghi O, Deutsch E, Guigay J, Temam S, Bourhis J. Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome European Journal of Cancer. 49: 1324-1334. PMID 23312882 DOI: 10.1016/J.Ejca.2012.12.008 |
0.306 |
|
| 2013 |
Levy A, Hollebecque A, Bourgier C, Loriot Y, Guigay J, Robert C, Delaloge S, Bahleda R, Massard C, Soria J, Deutsch E. Targeted therapy-induced radiation recall. European Journal of Cancer. 49: 1662-1668. PMID 23312391 DOI: 10.1016/J.Ejca.2012.12.009 |
0.34 |
|
| 2013 |
Clémenson C, Chargari C, Deutsch E. Combination of vascular disrupting agents and ionizing radiation. Critical Reviews in Oncology Hematology. 86: 143-160. PMID 23177097 DOI: 10.1016/J.Critrevonc.2012.10.002 |
0.336 |
|
| 2013 |
Levy A, Chargari C, Cheminant M, Simon N, Bourgier C, Deutsch E. Radiation therapy and immunotherapy: Implications for a combined cancer treatment Critical Reviews in Oncology Hematology. 85: 278-287. PMID 23036459 DOI: 10.1016/J.Critrevonc.2012.09.001 |
0.37 |
|
| 2013 |
Chargari C, Soria JC, Deutsch E. Controversies and challenges regarding the impact of radiation therapy on survival Annals of Oncology. 24: 38-46. PMID 22898033 DOI: 10.1093/Annonc/Mds217 |
0.348 |
|
| 2013 |
Clémenson C, Jouannot E, Merino-Trigo A, Rubin-Carrez C, Deutsch E. The vascular disrupting agent ombrabulin (AVE8062) enhances the efficacy of standard therapies in head and neck squamous cell carcinoma xenograft models Investigational New Drugs. 31: 273-284. PMID 22810221 DOI: 10.1007/S10637-012-9852-4 |
0.358 |
|
| 2013 |
Helissey C, Roquet F, Lanoy E, Varga A, Massard C, Gazzah A, Ribrag V, Bahleda R, Angevin E, Deutsch E, Soria J, Hollebecque A. Safety and tolerability in patients over age 75 included in phase I: The Institut Gustave Roussy experience. Journal of Clinical Oncology. 31: 9556-9556. DOI: 10.1200/Jco.2013.31.15_Suppl.9556 |
0.307 |
|
| 2013 |
Chargari C, Clémenson C, Mondini M, Ferte C, Jacquet-Bescond A, Cattan V, Depil S, Deutsch E. Abstract C219: Novel MET/FGFR/AXL kinase inhibitor S49076 exerts radiosensitizing activity in vitro and in vivo. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-C219 |
0.36 |
|
| 2013 |
Deutsch E, Lepechoux C, Pignon JP, Tao YT, Rivera S, Bourgier BC, Angokai M, Bahleda R, Slimane K, Angevin E, Besse BB, Soria JC. L03.06 Phase I Trial Of Rad001 (Everolimus) In Combination With Radiotherapy In Non-Small Cell Lung Cancer Annals of Oncology. 24. DOI: 10.1093/Annonc/Mdt042.13 |
0.316 |
|
| 2013 |
Helou J, Dumas I, Tournissoux G, Blanchard P, Ezra P, Meder CH, Deutsch E. Vaginal Sparing Using a Mold in Anal Cancer Female Patients Treated With Intensity Modulated Radiation Therapy: A Dosimetric Feasibility Study International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.881 |
0.331 |
|
| 2012 |
Chargari C, Moncharmont C, Lévy A, Guy JB, Bertrand G, Guilbert M, Rousseau C, Védrine L, Alphonse G, Toillon RA, Rodriguez-Lafrasse C, Deutsch E, Magné N. [Cancer stem cells, cornerstone of radioresistance and perspectives for radiosensitization: glioblastoma as an example]. Bulletin Du Cancer. 99: 1153-60. PMID 23228708 DOI: 10.1684/Bdc.2012.1666 |
0.351 |
|
| 2012 |
Maggiorella L, Barouch G, Devaux C, Pottier A, Deutsch E, Bourhis J, Borghi E, Levy L. Nanoscale radiotherapy with hafnium oxide nanoparticles. Future Oncology (London, England). 8: 1167-81. PMID 23030491 DOI: 10.2217/Fon.12.96 |
0.313 |
|
| 2012 |
Lynch DR, Deutsch EC, Wilson RB, Tennekoon G. Unanswered questions in Friedreich ataxia. Journal of Child Neurology. 27: 1223-9. PMID 22832776 DOI: 10.1177/0883073812453498 |
0.464 |
|
| 2012 |
Brigatti KW, Deutsch EC, Lynch DR, Farmer JM. Novel diagnostic paradigms for Friedreich ataxia. Journal of Child Neurology. 27: 1146-51. PMID 22752491 DOI: 10.1177/0883073812448440 |
0.445 |
|
| 2012 |
Deutsch EC, Seyer LA, Perlman SL, Yu J, Lynch DR. Clinical monitoring in a patient with Friedreich ataxia and osteogenic sarcoma. Journal of Child Neurology. 27: 1159-63. PMID 22752483 DOI: 10.1177/0883073812448460 |
0.482 |
|
| 2012 |
Lynch DR, Willi SM, Wilson RB, Cotticelli MG, Brigatti KW, Deutsch EC, Kucheruk O, Shrader W, Rioux P, Miller G, Hawi A, Sciascia T. A0001 in Friedreich ataxia: biochemical characterization and effects in a clinical trial. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1026-33. PMID 22744651 DOI: 10.1002/Mds.25058 |
0.466 |
|
| 2012 |
Bourgier C, Levy A, Vozenin M, Deutsch E. Pharmacological strategies to spare normal tissues from radiation damage: useless or overlooked therapeutics? Cancer and Metastasis Reviews. 31: 699-712. PMID 22706781 DOI: 10.1007/S10555-012-9381-9 |
0.362 |
|
| 2012 |
Ray-Coquard I, Chauvin F, Leblanc E, Caux C, Hoarau H, Bonnetain F, Christophe V, Sastre-Garau X, Lazennec G, Poulain L, Haie-Meder C, Pujade-Lauraine E, Salzet M, Deutsch E, Devouassoux M, et al. [PAIR-gynaecology: multi/interdisciplinary for gynecologic cancer research. Problems needed to be resolved]. Bulletin Du Cancer. 99: 479-98. PMID 22469552 DOI: 10.1684/Bdc.2012.1558 |
0.312 |
|
| 2012 |
Clémenson C, Chargari C, Désiré L, Casagrande AS, Bourhis J, Deutsch E. Assessment of the novel tubulin-binding agent EHT 6706 in combination with ionizing radiation or chemotherapy. Investigational New Drugs. 30: 2173-86. PMID 22246215 DOI: 10.1007/S10637-011-9785-3 |
0.344 |
|
| 2012 |
Massard C, Salazar R, Armand JP, Majem M, Deutsch E, García M, Oaknin A, Fernández-García EM, Soto A, Soria JC. Phase I dose-escalating study of ES-285 given as a three-hour intravenous infusion every three weeks in patients with advanced malignant solid tumors Investigational New Drugs. 30: 2318-2326. PMID 22215532 DOI: 10.1007/S10637-011-9772-8 |
0.302 |
|
| 2012 |
Gomez-Roca CA, Lacroix L, Massard C, Baere TD, Deschamps F, Pramod R, Bahleda R, Deutsch E, Bourgier C, Angevin E, Lazar V, Ribrag V, Koscielny S, Chami L, Lassau N, et al. Sequential research-related biopsies in phase I trials: acceptance, feasibility and safety Annals of Oncology. 23: 1301-1306. PMID 21917737 DOI: 10.1093/Annonc/Mdr383 |
0.308 |
|
| 2012 |
Mordant P, Loriot Y, Lahon B, Castier Y, Lesèche G, Soria J, Massard C, Deutsch E. Minimal residual disease in solid neoplasia: New frontier or red-herring? Cancer Treatment Reviews. 38: 101-110. PMID 21612875 DOI: 10.1016/J.Ctrv.2011.04.014 |
0.337 |
|
| 2012 |
Santos MA, Lefeuvre D, Teuff GL, Bouda D, Bourgier C, Domont J, Dhermain F, Soria J, Deutsch E, Pignon J. Evaluation of toxicities of target therapy phase I and II trials on glioblastoma multiforme patients treated by curative radiotherapy: A meta-analysis. Journal of Clinical Oncology. 30: 3063-3063. DOI: 10.1200/Jco.2012.30.15_Suppl.3063 |
0.317 |
|
| 2012 |
Loriot Y, Mordant P, Dugué D, Gombos A, Opolon P, Vozenin M, Bourhis J, Geneste O, Kraus-Berthier L, Pierré A, Depil S, Soria J, Deutsch E. Abstract 4891: Radiation enhances the efficacy of Bcl-2 and Bcl-XLinhibition in small cell lung cancer: A new concept of using radiation for targeted therapy through contextual oncogene addiction Cancer Research. 72: 4891-4891. DOI: 10.1158/1538-7445.Am2012-4891 |
0.349 |
|
| 2012 |
Santos M, Lefeuvre D, Teuff GL, Bourgier C, Pechoux CL, Soria J, Pignon J, Deutsch E. Meta-analysis of Toxicities in Phase I or II Trials Studying the Use of Target Therapy (TT) Combined With Radiation Therapy in Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC) International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.283 |
0.363 |
|
| 2011 |
Deutsch E, Lemanski C, Paris E, Delarochefordiere A, Martel-Lafay I, Rio E, Miglianico L, Becouarn Y, Pignon J, Berille J, Ezra P, Azria D. Cetuximab plus radiochemotherapy in locally advanced anal cancer: Interim results of the French multicenter phase II trial ACCORD16. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 4098. PMID 28020446 DOI: 10.1200/Jco.2011.29.15_Suppl.4098 |
0.339 |
|
| 2011 |
Lu B, Chiou S, Deutsch E, Lorico A. Cancer Stem Cells Journal of Oncology. 2011: 269437-269437. PMID 21603197 DOI: 10.1155/2011/269437 |
0.308 |
|
| 2011 |
Mazeron R, Anderson B, Supiot S, Paris F, Deutsch E. Current state of knowledge regarding the use of antiangiogenic agents with radiation therapy. Cancer Treatment Reviews. 37: 476-86. PMID 21546163 DOI: 10.1016/J.Ctrv.2011.03.004 |
0.326 |
|
| 2011 |
Soria J-, Deutsch E. Hemorrhage caused by antiangiogenic therapy within previously irradiated areas: expected consequence of tumor shrinkage or a warning for antiangiogenic agents combined to radiotherapy? Annals of Oncology. 22: 1247-1249. PMID 21382869 DOI: 10.1093/Annonc/Mdq775 |
0.312 |
|
| 2011 |
Desbat NH, Auberdiac P, Chargari C, Merrouche Y, Deutsch É, Schmitt T, Laroche Gd, Magné N. Cancer du canal anal : état des lieux, enjeux en oncogériatrie et thérapies moléculaires ciblées Bulletin Du Cancer. 98: 146-153. PMID 21382795 DOI: 10.1684/Bdc.2011.1305 |
0.346 |
|
| 2011 |
Rivera C, Rivera S, Loriot Y, Vozenin MC, Deutsch E. Lung cancer stem cell: new insights on experimental models and preclinical data. Journal of Oncology. 2011: 549181. PMID 21209720 DOI: 10.1155/2011/549181 |
0.329 |
|
| 2011 |
Selak MA, Lyver E, Micklow E, Deutsch EC, Onder O, Selamoglu N, Yager C, Knight S, Carroll M, Daldal F, Dancis A, Lynch DR, Sarry JE. Blood cells from Friedreich ataxia patients harbor frataxin deficiency without a loss of mitochondrial function. Mitochondrion. 11: 342-50. PMID 21147271 DOI: 10.1016/J.Mito.2010.12.003 |
0.442 |
|
| 2011 |
Laurence M, Darmon A, Vivet S, Polrot M, Zhang P, Deutsch E, Bourhis J, Pottier A, Borghi E, Levy L. Abstract 2665: NBTXR3 hafnium oxide nanoparticle activated by ionizing radiation demonstrates marked radio-enhancement and antitumor effect via high energy deposit in human soft tissue sarcoma Cancer Research. 71: 2665-2665. DOI: 10.1158/1538-7445.Am2011-2665 |
0.362 |
|
| 2011 |
Mordant P, Loriot Y, Decraene C, Lahon B, Castier Y, Soria J, Deutsch E. Abstract 2374: First time identification of circulating tumor cellsin murine models of human non-small cell lung cancer Cancer Research. 71: 2374-2374. DOI: 10.1158/1538-7445.Am2011-2374 |
0.307 |
|
| 2011 |
Rivera S, Leteur C, Menard J, Lelievre H, Bescond AJ, Berthier LK, Depil S, Deutsch E. Abstract A107: S 78454/PCI-24781, a novel HDAC inhibitor, targets the DNA damage response leading to radiosensitization of both normoxic and hypoxic NSCLC cell lines. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-A107 |
0.304 |
|
| 2010 |
Deutsch EC, Santani AB, Perlman SL, Farmer JM, Stolle CA, Marusich MF, Lynch DR. A rapid, noninvasive immunoassay for frataxin: utility in assessment of Friedreich ataxia. Molecular Genetics and Metabolism. 101: 238-45. PMID 20675166 DOI: 10.1016/J.Ymgme.2010.07.001 |
0.478 |
|
| 2010 |
Loriot Y, Mordant P, Dorvault N, Rouge TDLM, Bourhis J, Soria J-, Deutsch E. BMS-690514, a VEGFR and EGFR tyrosine kinase inhibitor, shows anti-tumoural activity on non-small-cell lung cancer xenografts and induces sequence-dependent synergistic effect with radiation British Journal of Cancer. 103: 347-353. PMID 20628392 DOI: 10.1038/Sj.Bjc.6605748 |
0.34 |
|
| 2010 |
Bahleda R, Massard C, Deutsch E, Ribrag V, Loriot Y, Kroesser S, Gianella-Borradori A, Trandafir L, Soria J. Abstract 2746: A phase I, dose-escalation study of the Eg5-inhibitor EMD534085 in subjects with advanced solid tumors and lymphoma Cancer Research. 70: 2746-2746. DOI: 10.1158/1538-7445.Am10-2746 |
0.307 |
|
| 2009 |
Tao Y, Leteur C, Calderaro J, Girdler F, Zhang P, Frascogna V, Varna M, Opolon P, Castedo M, Bourhis J, Kroemer G, Deutsch E. The aurora B kinase inhibitor AZD1152 sensitizes cancer cells to fractionated irradiation and induces mitotic catastrophe. Cell Cycle (Georgetown, Tex.). 8: 3172-81. PMID 19755861 DOI: 10.4161/Cc.8.19.9729 |
0.341 |
|
| 2009 |
Loriot Y, Mordant P, Deutsch E, Olaussen KA, Soria J. Are RAS mutations predictive markers of resistance to standard chemotherapy Nature Reviews Clinical Oncology. 6: 528-534. PMID 19597509 DOI: 10.1038/Nrclinonc.2009.106 |
0.327 |
|
| 2009 |
Mangoni M, Yue X, Morin C, Violot D, Frascogna V, Tao Y, Opolon P, Castaing M, Auperin A, Biti G, Barritault D, Vozenin-Brotons MC, Deutsch E, Bourhis J. Differential effect triggered by a heparan mimetic of the RGTA family preventing oral mucositis without tumor protection. International Journal of Radiation Oncology, Biology, Physics. 74: 1242-50. PMID 19545790 DOI: 10.1016/J.Ijrobp.2009.03.006 |
0.35 |
|
| 2009 |
Goéré D, Bonnet S, Pocard M, Deutsch E, Lasser P, Elias D. Oncologic and functional results after abdominoperineal resection plus pseudocontinent perineal colostomy for epidermoid carcinoma of the anus. Diseases of the Colon and Rectum. 52: 958-63. PMID 19502862 DOI: 10.1007/Dcr.0B013E31819F2A4B |
0.329 |
|
| 2009 |
Harrington KJ, El-Hariry IA, Holford CS, Lusinchi A, Nutting CM, Rosine D, Tanay M, Deutsch E, Matthews J, D'Ambrosio C, Turner SJ, Pandeshwara JS, Bourhis J. Phase i study of lapatinib in combination with chemoradiation in patients with locally advanced squamous cell carcinoma of the head and neck Journal of Clinical Oncology. 27: 1100-1107. PMID 19171712 DOI: 10.1200/Jco.2008.17.5349 |
0.331 |
|
| 2009 |
Magné N, Chargari C, Soria J, Deutsch E. Concomitant chemo-radiotherapy in clinical trials: to promote step by step rational development. Critical Reviews in Oncology Hematology. 70: 206-215. PMID 19042138 DOI: 10.1016/J.Critrevonc.2008.09.016 |
0.327 |
|
| 2008 |
Magné N, Chargari C, Deutsch E, Castadot P, Ghalibafian M, Bourhis J, Haie-Meder C. Molecular profiling of uterine cervix carcinoma: an overview with a special focus on rationally designed target-based anticancer agents Cancer and Metastasis Reviews. 27: 737-750. PMID 18787931 DOI: 10.1007/S10555-008-9162-7 |
0.35 |
|
| 2008 |
Magné N, Chargari C, Castadot P, Ghalibafian M, Soria J, Haie-Meder C, Bourhis J, Deutsch E. The efficacy and toxicity of EGFR in the settings of radiotherapy: Focus on published clinical trials. European Journal of Cancer. 44: 2133-2143. PMID 18692389 DOI: 10.1016/J.Ejca.2008.06.029 |
0.318 |
|
| 2008 |
Goéré D, Patriti A, Deutsch E, Elias D, Ducreux M. A prolonged follow-up provides new insights into locally advanced pancreatic cancer treatment. Gastroenterologie Clinique Et Biologique. 32: 649-652. PMID 18487030 DOI: 10.1016/J.Gcb.2008.01.043 |
0.307 |
|
| 2008 |
Loriot Y, Perlemuter G, Malka D, Penault-Llorca F, Penault-Lorca F, Boige V, Deutsch E, Massard C, Armand JP, Soria JC. Drug insight: gastrointestinal and hepatic adverse effects of molecular-targeted agents in cancer therapy. Nature Clinical Practice. Oncology. 5: 268-78. PMID 18349858 DOI: 10.1038/Ncponc1087 |
0.323 |
|
| 2008 |
Milliat F, Sabourin J, Tarlet G, Holler V, Deutsch E, Buard V, Tamarat R, Atfi A, Benderitter M, François A. Essential Role of Plasminogen Activator Inhibitor Type-1 in Radiation Enteropathy American Journal of Pathology. 172: 691-701. PMID 18276785 DOI: 10.2353/Ajpath.2008.070930 |
0.321 |
|
| 2008 |
Tao Y, Leteur C, Frascogna V, Zhang P, Opolon P, Mundt K, Kroemer G, Bourhis J, Deutsch E. Enhancement of Radiation Response in p53-deficient Cancer Cells In vivo using Different Schedules of Radiation and AZD1152, an Aurora B Kinase Inhibitor International Journal of Radiation Oncology*Biology*Physics. 72: S713. DOI: 10.1016/J.Ijrobp.2008.06.547 |
0.324 |
|
| 2007 |
Tao Y, Zhang P, Girdler F, Frascogna V, Castedo M, Bourhis J, Kroemer G, Deutsch E. Enhancement of radiation response in p53-deficient cancer cells by the Aurora-B kinase inhibitor AZD1152. Oncogene. 27: 3244-55. PMID 18084327 DOI: 10.1038/Sj.Onc.1210990 |
0.301 |
|
| 2007 |
Ducreux M, Boige V, Goéré D, Deutsch E, Ezra P, Elias D, Malka D. Pancreatic cancer: From pathogenesis to cure Best Practice & Research in Clinical Gastroenterology. 21: 997-1014. PMID 18070700 DOI: 10.1016/J.Bpg.2007.10.025 |
0.346 |
|
| 2007 |
Italiano A, Massard C, Bahleda R, Vataire A-, Deutsch E, Magné N, Pignon J-, Vassal G, Armand J-, Soria J-. Treatment outcome and survival in participants of phase I oncology trials carried out from 2003 to 2006 at Institut Gustave Roussy Annals of Oncology. 19: 787-792. PMID 18042834 DOI: 10.1093/Annonc/Mdm548 |
0.306 |
|
| 2007 |
Tao Y, Zhang P, Frascogna V, Lecluse Y, Auperin A, Bourhis J, Deutsch E. Enhancement of radiation response by inhibition of Aurora-A kinase using siRNA or a selective Aurora kinase inhibitor PHA680632 in p53-deficient cancer cells. British Journal of Cancer. 97: 1664-1672. PMID 18026198 DOI: 10.1038/Sj.Bjc.6604083 |
0.346 |
|
| 2007 |
Deutsch E, Ezra P, Mangoni M, Ducreux M. Radiotherapy for localized rectal cancer Annals of Oncology. 18: 105-113. PMID 17631562 DOI: 10.1093/Annonc/Mdm304 |
0.372 |
|
| 2006 |
Massard C, Deutsch E, Soria J-. Tumour stem cell-targeted treatment: elimination or differentiation Annals of Oncology. 17: 1620-1624. PMID 16600978 DOI: 10.1093/Annonc/Mdl074 |
0.305 |
|
| 2005 |
Kaliski A, Maggiorella L, Cengel KA, Mathe D, Rouffiac V, Opolon P, Lassau N, Bourhis J, Deutsch E. Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion Molecular Cancer Therapeutics. 4: 1717-1728. PMID 16275993 DOI: 10.1158/1535-7163.Mct-05-0179 |
0.305 |
|
| 2005 |
Deutsch E, Soria JC, Armand JP. New concepts for phase I trials: evaluating new drugs combined with radiation therapy. Nature Clinical Practice. Oncology. 2: 456-65. PMID 16264990 DOI: 10.1038/Ncponc0295 |
0.368 |
|
| 2003 |
Soria J, Kim ES, Fayette J, Lantuejoul S, Deutsch E, Hong WK. Chemoprevention of lung cancer Lancet Oncology. 4: 659-669. PMID 14602246 DOI: 10.1016/S1470-2045(03)01244-0 |
0.33 |
|
| 2003 |
M'kacher R, Bennaceur A, Farace F, Laugé A, Plassa LF, Wittmer E, Dossou J, Violot D, Deutsch E, Bourhis J, Stoppa-Lyonnet D, Ribrag V, Carde P, Parmentier C, Bernheim A, et al. Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphoma. Oncogene. 22: 7905-7912. PMID 12970738 DOI: 10.1038/Sj.Onc.1206826 |
0.334 |
|
| 2003 |
Abdulkarim B, Sabri S, Zelenika D, Deutsch E, Frascogna V, Klijanienko J, Vainchenker W, Joab I, Bourhis J. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies. Oncogene. 22: 2260-2271. PMID 12700662 DOI: 10.1038/Sj.Onc.1206402 |
0.322 |
|
| 2003 |
M'kacher R, Laithier V, Valent A, Delhommeau F, Violot D, Deutsch E, Dossou J, Béron-Gaillard N, Girinsky T, Bourhis J, Carde P, Bernheim A, Parmentier C. Sensitivity to radiation and alkylating agent of peripheral lymphocytes and fibroblasts in a Hoyeraal-Hreidarsson syndrome patient. Pediatric Hematology and Oncology. 20: 651-656. DOI: 10.1080/08880010390243086 |
0.315 |
|
| 2002 |
Abdulkarim B, Sabri S, Deutsch E, Chagraoui H, Maggiorella L, Thierry J, Eschwege F, Vainchenker W, Chouaïb S, Bourhis J. Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers. Oncogene. 21: 2334-2346. PMID 11948417 DOI: 10.1038/Sj.Onc.1205006 |
0.311 |
|
| 2001 |
Wen B, Deutsch E, Marangoni E, Frascona V, Maggiorella L, Abdulkarim B, Chavaudra N, Bourhis J. Tyrphostin AG 1024 modulates radiosensitivity in human breast cancer cells. British Journal of Cancer. 85: 2017-2021. PMID 11747348 DOI: 10.1054/Bjoc.2001.2171 |
0.317 |
|
| 2000 |
Abdulkarim B, Sabri S, Deutsch E, Vaganay S, Marangoni E, Vainchenker W, Bongrand P, Busson P, Bourhis J. Radiation-induced expression of functional Fas ligand in EBV-positive human nasopharyngeal carcinoma cells. International Journal of Cancer. 86: 229-237. PMID 10738250 DOI: 10.1002/(Sici)1097-0215(20000415)86:2<229::Aid-Ijc12>3.0.Co;2-1 |
0.346 |
|
| 2000 |
Bourhis J, Crevoisier RD, Abdulkarim B, Deutsch E, Lusinchi A, Luboinski B, Wibault P, Eschwege F. A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma International Journal of Radiation Oncology Biology Physics. 46: 1105-1108. PMID 10725619 DOI: 10.1016/S0360-3016(99)00532-5 |
0.335 |
|
| Show low-probability matches. |